c3 (computerized cognitive composite) Search Results


c3 (computerized cognitive composite)  (CogState Ltd)
90
CogState Ltd c3 (computerized cognitive composite)
Validation of primarily in‐clinic computerized and tablet‐based cognitive assessment
C3 (Computerized Cognitive Composite), supplied by CogState Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c3 (computerized cognitive composite)/product/CogState Ltd
Average 90 stars, based on 1 article reviews
c3 (computerized cognitive composite) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
computerized cognitive composite (c3)  (Florey Institute of Neuroscience and Mental Health)
90
Florey Institute of Neuroscience and Mental Health computerized cognitive composite (c3)
Validation of primarily in‐clinic computerized and tablet‐based cognitive assessment
Computerized Cognitive Composite (C3), supplied by Florey Institute of Neuroscience and Mental Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/computerized cognitive composite (c3)/product/Florey Institute of Neuroscience and Mental Health
Average 90 stars, based on 1 article reviews
computerized cognitive composite (c3) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Validation of primarily in‐clinic computerized and tablet‐based cognitive assessment

Journal: Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring

Article Title: Current advances in digital cognitive assessment for preclinical Alzheimer's disease

doi: 10.1002/dad2.12217

Figure Lengend Snippet: Validation of primarily in‐clinic computerized and tablet‐based cognitive assessment

Article Snippet: A more recent iteration of Cogstate tasks is the C3 (Computerized Cognitive Composite) which includes the CBB in addition to two measures potentially sensitive to changes in early AD based on evidence from the cognitive neuroscience literature: the Behavioral Pattern Separation–Object Version (BPS‐O) and The Face‐Name Associative Memory Test (FNAME).

Techniques: Biomarker Discovery